The dysfunction of T follicular helper cells

Current Opinion in HIV and AIDS

Volumn 9, Issue 5, 2014, Pages 485-491

  Cubas, Rafael ^a   Perreau, Matthieu ^b  

^a Vaccine and Gene Therapy Institute of Florida   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

B cells and dysfunction; HIV; T follicular helper cells

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 21; NEUTRALIZING ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY CELL; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T FOLLICULAR HELPER CELL; T LYMPHOCYTE; ANIMAL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MACACA; PATHOPHYSIOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ANIMALS; B-LYMPHOCYTES; HIV; HIV INFECTIONS; HUMANS; MACACA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84906043406     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000095     Document Type: Review

References (99)

1. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011; 29:621-663.
2. Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol 2012; 30:429-457.
3. Rolf J, Fairfax K, Turner M. Signaling pathways in T follicular helper cells. J Immunol 2010; 184:6563-6568.
4. Victora GD, Schwickert TA, Fooksman DR, et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 2010; 143:592-605.
5. Zotos D, Coquet JM, Zhang Y, et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 2010; 207:365-378.
6. Kim CH, Rott LS, Clark-Lewis I, et al. Subspecialization of CXCR5\+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5\+ T cells. J Exp Med 2001; 193:1373-1381. (Pubitemid 32565966)
7. Schaerli P, Willimann K, Lang AB, et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000; 192:1553-1562.
8. Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000; 192:1545-1552.
9. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: Lineage and location. Immunity 2009; 30:324-335.
10. Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol 2009; 10:375-384.
11. Good-Jacobson KL, Shlomchik MJ. Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: The influence of germinal center interactions and dynamics. J Immunol 2010; 185:3117-3125.
12. Goodnow CC, Vinuesa CG, Randall KL, et al. Control systems and decision making for antibody production. Nat Immunol 2010; 11:681-688.
13. McHeyzer-Williams M, Okitsu S, Wang N, McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev Immunol 2012; 12:24-34.
14. Tangye SG, Tarlinton DM. Memory B cells: Effectors of long-lived immune responses. Eur J Immunol 2009; 39:2065-2075.
15. Ackerman ME, Alter G. Opportunities to exploit nonneutralizing HIV-specific antibody activity. Curr HIV Res 2013; 11:365-377.
16. Forthal D, Hope TJ, Alter G. New paradigms for functional HIV-specific nonneutralizing antibodies. Curr Opin HIV AIDS 2013; 8:393-401.
17. Lai JI, Licht AF, Dugast AS, et al. Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers. J Virol 2014; 88:2799-2809.
18. Excler JL, Tomaras GD, Russell ND. Novel directions in HIV-1 vaccines revealed from clinical trials. Curr Opin HIV AIDS 2013; 8:421-431.
19. Hessell AJ, Hangartner L, Hunter M, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007; 449:101-104. (Pubitemid 47373775)
20. Ackerman ME, Crispin M, Yu X, et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest 2013; 123:2183-2192.
21. Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 2004; 173:68-78. (Pubitemid 38797327)
22. Johnston RJ, Poholek AC, DiToro D, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009; 325:1006-1010.
23. Ma CS, Deenick EK, Batten M, Tangye SG. The origins, function, and regulation of T follicular helper cells. J Exp Med 2012; 209:1241-1253.
24. Nutt SL, Tarlinton DM.Germinal center B and follicular helper T cells: Siblings, cousins or just good friends? Nat Immunol 2011; 12:472-477.
25. Liu X, Chen X, Zhong B, et al. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature 2014; 507:513-518.
26. Yu D, Rao S, Tsai LM, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009; 31:457-468.
27. Bossaller L, Burger J, Draeger R, et al. ICOS deficiency is associated with a severe reduction of CXCR5\+ CD4 germinal center Th cells. J Immunol 2006; 177:4927-4932. (Pubitemid 44469829)
28. Simpson N, Gatenby PA, Wilson A, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 2010; 62:234-244.
29. Morita R, Schmitt N, Bentebibel SE, et al. Human blood CXCR5\+CD4\+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011; 34:108-121.
30. Chevalier N, Jarrossay D, Ho E, et al. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J Immunol 2011; 186:5556-5568.
31. Pallikkuth S, Parmigiani A, Silva SY, et al. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood 2012; 120:985-993.
32. Locci M, Havenar-Daughton C, Landais E, et al. Human circulating PD-1\+CXCR3-CXCR5\+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 2013; 39:758-769.
33. Boswell KL, Paris R, Boritz E, et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog 2014; 10:e1003853.
34. Perreau M, Savoye AL, De Crignis E, et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 2013; 210:143-156.
35. Lindqvist M, van Lunzen J, Soghoian DZ, et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 2012; 122:3271-3280.
36. Petrovas C, Yamamoto T, Gerner MY, et al. CD4 T follicular helper cell dynamics during SIV infection. J Clin Invest 2012; 122:3281-3294.
37. Hong JJ, Amancha PK, Rogers K, et al. Spatial alterations between CD4(\+) T follicular helper, B, and CD8\+ T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J Immunol 2012; 188:3247-3256.
38. Xu Y, Weatherall C, Bailey M, et al. Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques. J Virol 2013; 87:3760-3773.
39. Kim HJ, Verbinnen B, Tang X, et al. Inhibition of follicular T-helper cells by CD8(\+) regulatory T cells is essential for self tolerance. Nature 2010; 467:328-332.
40. Cubas RA, Mudd JC, Savoye AL, et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med 2013; 19:494-499.
41. Ozaki K, Spolski R, Feng CG, et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002; 298:1630-1634. (Pubitemid 35387203)
42. Avery DT, Deenick EK, Ma CS, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010; 207:155-171.
43. Tangye SG, Ma CS, Brink R, Deenick EK. The good, the bad and the ugly-TFH cells in human health and disease. Nat Rev Immunol 2013; 13:412-426.
44. King C, Tangye SG, Mackay CR. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 2008; 26:741-766. (Pubitemid 351600391)
45. Ma CS, Deenick EK. Human T follicular helper (Tfh) cells and disease. Immunol Cell Biol 2014; 92:64-71.
46. Pratama A, Vinuesa CG. Control of TFH cell numbers: Why and how? Immunol Cell Biol 2014; 92:40-48.
47. Brenchley JM, Schacker TW, Ruff LE, et al. CD4\+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759. (Pubitemid 39299461)
48. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362:359-362. (Pubitemid 23101311)
49. Pantaleo G, Graziosi C, Butini L, et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 1991; 88:9838-9842. (Pubitemid 21915729)
50. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362:355-358. (Pubitemid 23101310)
51. Chakrabarti L, Isola P, Cumont MC, et al. Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol 1994; 144:1226-1237. (Pubitemid 24172085)
52. Hufert FT, van Lunzen J, Janossy G, et al. Germinal centre CD4\+T cells are an important site of HIV replication in vivo. AIDS 1997; 11:849-857. (Pubitemid 27226407)
53. Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8\+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68:6103-6110. (Pubitemid 24258634)
54. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-4655. (Pubitemid 24183063)
55. Connick E, Mattila T, Folkvord JM, et al. CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J Immunol 2007; 178:6975-6983. (Pubitemid 46847424)
56. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387:183-188. (Pubitemid 27209433)
57. Chun TW, Stuyver L, Mizell SB, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997; 94:13193-13197. (Pubitemid 27518498)
58. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295-1300. (Pubitemid 27495742)
59. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278:1291-1295. (Pubitemid 27495741)
60. Siliciano JD, Kajdas J, Finzi D, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4\+ T cells. Nat Med 2003; 9:727-728. (Pubitemid 36749221)
61. Chun TW, Finzi D, Margolick J, et al. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency. Nat Med 1995; 1:1284-1290.
62. Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009; 15:893-900.
63. Mascola JR, Montefiori DC. The role of antibodies in HIV vaccines. Annu Rev Immunol 2010; 28:413-444.
64. Pantophlet R, Burton DR. GP120: Target for neutralizing HIV-1 antibodies. Annu Rev Immunol 2006; 24:739-769.
65. Kwong PD, Mascola J.R. Human antibodies that neutralize HIV-1: Identification, structures, and B cell ontogenies. Immunity 2012; 37:412-425.
66. Doria-Rose NA, Klein RM, Manion MM, et al. Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J Virol 2009; 83:188-199.
67. Gray ES, Madiga MC, Hermanus T, et al. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4\+ T cell decline and high viral load during acute infection. J Virol 2011; 85:4828-4840.
68. Gray ES, MoodyMA, Wibmer CK, et al. Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual. J Virol 2011; 85:7719-7729.
69. Mikell I, Sather DN, Kalams SA, et al. Characteristics of the earliest crossneutralizing antibody response to HIV-1. PLoS Pathog 2011; 7:e1001251.
70. Starcich BR, Hahn BH, Shaw GM, et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986; 45:637-648. (Pubitemid 16063128)
71. Wyatt R, Kwong PD, Desjardins E, et al. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 1998; 393:705-711. (Pubitemid 28289663)
72. Kwong PD, Doyle ML, Casper DJ, et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 2002; 420:678-682. (Pubitemid 36764500)
73. Lane HC, Masur H, Edgar LC, et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309:453-458. (Pubitemid 13041485)
74. Vago L, Antonacci MC, Cristina S, et al. Morphogenesis, evolution and prognostic significance of lymphatic tissue lesions in HIV infection. Appl Pathol 1989; 7:298-309. (Pubitemid 20147416)
75. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004; 2:11-21. (Pubitemid 38854921)
76. Cagigi A, Nilsson A, De Milito A, Chiodi F. B cell immunopathology during HIV-1 infection: Lessons to learn for HIV-1 vaccine design. Vaccine 2008; 26:3016-3025.
77. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9:235-245.
78. Moir S, Buckner CM, Ho J, et al. B cells in early and chronic HIV infection: Evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood 2010; 116:5571-5579.
79. van Grevenynghe J, Cubas RA, Noto A, et al. Loss of memory B cells during chronic HIV infection is driven by Foxo3a-and TRAIL-mediated apoptosis. J Clin Invest 2011; 121:3877-3888.
80. Morris L, Binley JM, Clas BA, et al. HIV-1 antigen-specific and-nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1998; 188:233-245. (Pubitemid 28357752)
81. Moir S, Ho J,Malaspina A, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008; 205:1797-1805.
82. Wollenberg I, Agua-Doce A, Hernandez A, et al. Regulation of the germinal center reaction by Foxp3\+ follicular regulatory T cells. J Immunol 2011; 187:4553-4560.
83. Chung Y, Tanaka S, Chu F, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 2011; 17:983-988.
84. Lim HW, Hillsamer P, Kim CH. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 2004; 114:1640-1649. (Pubitemid 40385555)
85. Tsuji M, Komatsu N, Kawamoto S, et al. Preferential generation of follicular B helper T cells from Foxp3\+ T cells in gut Peyer's patches. Science 2009; 323:1488-1492.
86. Linterman MA, Pierson W, Lee SK, et al. Foxp3\+ follicular regulatory T cells control the germinal center response. Nat Med 2011; 17:975-982.
87. Sage PT, Francisco LM, Carman CV, Sharpe AH. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat Immunol 2013; 14:152-161.
88. De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103:2180-2186. (Pubitemid 38326236)
89. Titanji K, De Milito A, Cagigi A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580-1587. (Pubitemid 44316125)
90. Hart M, Steel A, Clark SA, et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol 2007; 178:8212-8220. (Pubitemid 46898094)
91. Hale JS, Youngblood B, Latner DR, et al. Distinct memory CD4\+ T cells with commitment to T follicular helper-and T helper 1-cell lineages are generated after acute viral infection. Immunity 2013; 38:805-817.
92. Liu X, Yan X, Zhong B, et al. Bcl6 expression specifies the T follicular helper cell program in vivo. J Exp Med 2012; 209:1841-1852; S1841-1824.
93. Luthje K, Kallies A, Shimohakamada Y, et al. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat Immunol 2012; 13:491-498.
94. Pepper M, Pagan AJ, Igyarto BZ, et al. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 2011; 35:583-595.
95. Weber JP, Fuhrmann F, Hutloff A. T-follicular helper cells survive as long-term memory cells. Eur J Immunol 2012; 42:1981-1988.
96. Choi YS, Yang JA, Yusuf I, et al. Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J Immunol 2013; 190:4014-4026.
97. Ravirajan CT, Rahman MA, Papadaki L, et al. Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis. Eur J Immunol 1998; 28:339-350. (Pubitemid 28048304)
98. Pallikkuth S, Pilakka Kanthikeel S, Silva SY, et al. Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. J Immunol 2011; 186:6173-6181.
99. Bentebibel SE, Lopez S, Obermoser G, et al. Induction of ICOS\+CXCR3\+CXCR5\+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med 2013; 5:176-132.